Clinical Trials Logo

Clinical Trial Summary

To assess the efficacy and safety of larazotide acetate versus placebo for the treatment of persistent abdominal symptoms in adult celiac disease patients.


Clinical Trial Description

This is a phase 3, randomized, double-blind, placebo-controlled, multicenter, outpatient study to assess the efficacy and safety of larazotide acetate for the treatment of persistent abdominal symptoms in adult celiac disease patients with persistent abdominal symptoms (non-responsive celiac disease) on a GFD as an adjunct to a GFD. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03569007
Study type Interventional
Source Innovate Biopharmaceuticals
Contact Audrey Sharbaugh, PhD
Phone 9194180159
Email asharbaugh@innovatebiopharma.com
Status Not yet recruiting
Phase Phase 3
Start date October 2018
Completion date December 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02754609 - Hookworm Therapy for Coeliac Disease Phase 1
Terminated NCT01902368 - Celiac Disease Screening N/A
Completed NCT02312349 - Assessment of Gluten-Free Availability in Elaborated Food Stores in Three Neighbourhoods of Buenos Aires City N/A
Completed NCT02472704 - Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo N/A
Recruiting NCT01172665 - Celiac Disease Database N/A
Completed NCT01100099 - HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease Phase 2/Phase 3
Completed NCT00639444 - Risk of Celiac Disease and Age at Gluten Introduction N/A
Completed NCT00362856 - Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects Phase 2
Completed NCT02244047 - Cytokine Profile in Children With Celiac Disease Phase 1/Phase 2
Active, not recruiting NCT01695681 - Screen-detected Coeliac Disease, a Population Based Study N/A
Active, not recruiting NCT00617838 - Celiac Disease Prevention N/A
Completed NCT00671138 - Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivity Phase 2
Completed NCT00540657 - A Phase II Study of CCX282-B in Patients With Celiac Disease Phase 2
Completed NCT01137955 - Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease N/A
Recruiting NCT03775499 - Probiotic BL NCC 2705 and Gluten Sensitivity N/A
Recruiting NCT03288831 - Changes in Intestinal Permeability 4 Hours After Gluten Challenge N/A
Completed NCT01396213 - A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease Phase 2
Recruiting NCT03136731 - Evidence-based Screening Strategies for Celiac Disease N/A
Completed NCT00386165 - Safety Study of Larazotide Acetate to Treat Celiac Disease. Phase 1
Recruiting NCT03678935 - Effect of FODMAP Restriction on Persistent GI-symptoms in Coeliac Patients N/A